. Author manuscript; available in PMC: 2024 Jul 1.

Published in final edited form as: J Perinatol. 2023 Feb 3;43(7):849–855. doi: 10.1038/s41372-023-01625-4

Table 4:

Rates of Severe Maternal morbidity, stratified by MCD diagnosis and route of delivery

	N (%)	Unadjusted Odds Ratio (95% Confidence Interval)	Adjusted^* Odds Ratio (95% Confidence Interval)
Severe Maternal Morbidity
No MCD, Vaginal Delivery	174 (1.8)	1 (reference)	1 (reference)
No MCD, Cesarean Delivery	377 (9.0)	5.44 (4.53, 6.54)	5.10 (4.00, 6.46)
MCD, Vaginal Delivery	5 (4.0)	2.27 (0.92, 5.65)	2.33 (0.91, 5.99)
MCD, Cesarean Delivery	26 (28.3)	21.68 (13.24, 35.51)	18.57 (10.67, 32.30)
Non-Transfusion Severe Maternal Morbidity
No MCD, Vaginal Delivery	61 (0.6)	1 (reference)	1 (reference)
No MCD, Cesarean Delivery	101 (2.4)	3.92 (2.85, 5.40)	3.65 (2.49, 5.34)
MCD, Vaginal Delivery	4 (3.2)	5.21 (1.86, 14.58)	5.05 (1.68, 15.15)
MCD, Cesarean Delivery	14 (15.2)	28.51 (15.26, 53.28)	24.38 (10.95, 54.30)

Odds ratios compared to no MCD / vaginal delivery.

Models adjusted for patient age, race, parity, number of prior cesarean deliveries, body mass index, gestational age at delivery, and presence of selected comorbid conditions (alcohol use, asthma, cystic fibrosis, chronic kidney disease, gestational diabetes mellitus, pre-gestational diabetes, drug use, HIV/AIDS, multiple gestations, sickle cell anemia, systemic lupus erythematosus, and tobacco use)